SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 228 filers reported holding SAGE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 2.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $1,000 | 0.0% | 33 | 0.0% | 0.00% | – |
Q2 2022 | $1,000 | 0.0% | 33 | -21.4% | 0.00% | – |
Q1 2022 | $1,000 | -99.7% | 42 | -99.5% | 0.00% | -100.0% |
Q3 2021 | $354,000 | +378.4% | 7,995 | +515.0% | 0.02% | +533.3% |
Q2 2021 | $74,000 | +1133.3% | 1,300 | +1429.4% | 0.00% | – |
Q1 2021 | $6,000 | -14.3% | 85 | +1.2% | 0.00% | -100.0% |
Q4 2020 | $7,000 | +40.0% | 84 | 0.0% | 0.00% | – |
Q3 2020 | $5,000 | +66.7% | 84 | +6.3% | 0.00% | – |
Q2 2020 | $3,000 | 0.0% | 79 | -17.7% | 0.00% | – |
Q1 2020 | $3,000 | -40.0% | 96 | +33.3% | 0.00% | – |
Q4 2019 | $5,000 | -64.3% | 72 | -28.7% | 0.00% | -100.0% |
Q3 2019 | $14,000 | -26.3% | 101 | -1.0% | 0.00% | 0.0% |
Q2 2019 | $19,000 | +216.7% | 102 | +183.3% | 0.00% | – |
Q1 2019 | $6,000 | -100.0% | 36 | -98.1% | 0.00% | -100.0% |
Q2 2018 | $296,781,000 | +470981.0% | 1,896 | +387.4% | 0.03% | +333.3% |
Q1 2018 | $63,000 | +117.2% | 389 | +117.3% | 0.01% | +200.0% |
Q4 2017 | $29,000 | +2800.0% | 179 | +1018.8% | 0.00% | – |
Q3 2017 | $1,000 | – | 16 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RTW INVESTMENTS, LP | 5,149,482 | $105,976,340 | 2.24% |
Palo Alto Investors LP | 1,005,776 | $20,698,870 | 1.96% |
Boxer Capital, LLC | 1,094,000 | $22,514,520 | 1.20% |
Bellevue Group AG | 3,513,351 | $72,304,764 | 1.16% |
PDT Partners, LLC | 181,625 | $3,737,843 | 0.47% |
EASTERLY INVESTMENT PARTNERS LLC | 195,643 | $4,026,333 | 0.44% |
Harvest Investment Services, LLC | 30,302 | $623,615 | 0.40% |
Simplify Asset Management Inc. | 120,030 | $2,470,217 | 0.28% |
SAMLYN CAPITAL, LLC | 739,867 | $15,226,463 | 0.25% |
CAXTON ASSOCIATES LP | 68,035 | $1,400,160 | 0.19% |